BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22248133)

  • 1. Compulsive use of dopamine replacement therapy in Parkinson's disease: insights into the neurobiology of addiction.
    Brown RM; Lawrence AJ
    Addiction; 2012 Feb; 107(2):250-1. PubMed ID: 22248133
    [No Abstract]   [Full Text] [Related]  

  • 2. Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?
    Ambermoon P; Carter A; Hall W; Dissanayaka N; O'Sullivan J
    Addiction; 2012 Feb; 107(2):241-7. PubMed ID: 21793971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compulsive use of dopamine replacement therapy among Parkinson's disease patients: if it looks like a duck, swims like a duck and quacks like a duck..
    Kaye S
    Addiction; 2012 Feb; 107(2):251-3. PubMed ID: 22248134
    [No Abstract]   [Full Text] [Related]  

  • 4. Addiction as aberrant learning-evidence from Parkinson's disease.
    Dagher A
    Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine is not dopamine.
    Soyka M
    Addiction; 2012 Feb; 107(2):248. PubMed ID: 22248131
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
    Merims D; Giladi N
    Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compulsive singing: another aspect of punding in Parkinson's disease.
    Bonvin C; Horvath J; Christe B; Landis T; Burkhard PR
    Ann Neurol; 2007 Nov; 62(5):525-8. PubMed ID: 17696122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hedonistic homeostatic dysregulation.
    Kessel BL
    Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa addiction in non-parkinsonian patients.
    Steiner I; Wirguin I
    Neurology; 2003 Nov; 61(10):1451. PubMed ID: 14638980
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating debate in the field of addiction.
    Carter A; Hall W; Ambermoon P; Dissanayaka N; O'Sullivan J
    Addiction; 2012 Feb; 107(2):253. PubMed ID: 22248135
    [No Abstract]   [Full Text] [Related]  

  • 12. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
    Wenzelburger R
    Clin Neurophysiol; 2005 Sep; 116(9):1997-8. PubMed ID: 16055380
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M; Benecke R
    MMW Fortschr Med; 2005 May; 147 Spec No 2():28-31. PubMed ID: 15968869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic drugs, paraphilic fantasies, paraphilic behaviours and creativity in Parkinson's disease.
    Cannas A; Solla P; Floris GL; Serra C; Costantino E; Piras V; Marrosu F; Marrosu MG
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):563-4. PubMed ID: 20153398
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract]   [Full Text] [Related]  

  • 16. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report].
    Hol WM; van der Zwaard R; Hovestadt A; van Megen HJ
    Tijdschr Psychiatr; 2010; 52(4):259-63. PubMed ID: 20503167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rehabilitation goals and strategies in Parkinson's disease.
    Ceravolo MG
    Eur J Phys Rehabil Med; 2009 Jun; 45(2):205-8. PubMed ID: 19532108
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.